Investor Alert

press release

Aug. 23, 2019, 7:00 a.m. EDT

Nevro to Present at Morgan Stanley 17th Annual Healthcare Conference

REDWOOD CITY, Calif., Aug. 23, 2019 /PRNewswire/ -- Nevro Corp.  /zigman2/quotes/209913092/composite NVRO -1.38% , a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the Company will be participating in the Morgan Stanley 17 [th] Annual Healthcare Conference in New York City. Nevro Chairman, CEO and President D. Keith Grossman is scheduled to present on Monday, September 9, 2019 at 2:50 pm Eastern Time.

A live webcast of the presentation, as well as an archived recording, will be available on the "Investors" section of the Company's website at  www.nevro.com .

About Nevro Corp.  
Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Senza® System and Senza II™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.

Investor Relations Juliet Cunningham
Vice President, Investor Relations




View original content to download multimedia: http://www.prnewswire.com/news-releases/nevro-to-present-at-morgan-stanley-17th-annual-healthcare-conference-300906236.html

SOURCE Nevro Corp.

Copyright (C) 2019 PR Newswire. All rights reserved

$ 93.96
-1.31 -1.38%
Volume: 573,832
April 3, 2020 6:30p
P/E Ratio
Dividend Yield
Market Cap
$2.99 billion
Rev. per Employee

Link to MarketWatch's Slice.